Get the Stockscreener App
2.78
3.35%
0.09
Pre-market:
2.74
-0.04
-1.44%
Fortress Biotech Inc stock is traded at $2.78, with a volume of 556.47K.
It is up +3.35% in the last 24 hours and up +12.55% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
See More
Previous Close:
$2.69
Open:
$2.66
24h Volume:
556.47K
Relative Volume:
0.61
Market Cap:
$86.29M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.2508
EPS:
-11.0849
Net Cash Flow:
$-129.56M
1W Performance:
+0.72%
1M Performance:
+12.55%
6M Performance:
+50.27%
1Y Performance:
+27.52%
1-Day Range:
$2.63
$2.845
1-Week Range:
$2.485
$2.855
52-Week Range:
$1.325
$4.20
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
2.78 | 83.49M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Will Fortress Biotech Inc. stock gain from strong economyJuly 2025 Recap & Verified Swing Trading Watchlist - Newser
Why analysts remain bullish on Fortress Biotech Inc. stock2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
How Fortress Biotech Inc.(CNB0) stock reacts to monetary easingDollar Strength & Capital Efficiency Focused Ideas - Newser
Is Fortress Biotech Inc.(CNB0) stock a fit for income portfolios2025 Earnings Surprises & Trade Opportunity Analysis Reports - Newser
Is Fortress Biotech Inc.(CNB0) stock supported by free cash flow2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
Is Fortress Biotech Inc.(CNB0) stock undervalued historicallyMarket Sentiment Report & Daily Growth Stock Tips - Newser
Envestnet Asset Management Inc. Sells 98,195 Shares of Fortress Biotech, Inc. $FBIO - MarketBeat
Liquidity Mapping Around (FBIOP) Price Events - news.stocktradersdaily.com
Is Fortress Biotech Inc a good long term investmentPrice Gap Trading Strategies & You’ve Never Seen Stock Picks Like These - earlytimes.in
How Fortress Biotech Inc.(CNB0) stock trades pre earningsPortfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
Why Fortress Biotech Inc. stock is seen as undervaluedJuly 2025 Drop Watch & Consistent Growth Stock Picks - newser.com
Will Fortress Biotech Inc.(CNB0) stock benefit from infrastructure billCEO Change & AI Driven Price Predictions - newser.com
Fortress Biotech Inc. (FBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Fortress Biotech Inc.(CNB0) stock is favored by hedge funds2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Using data tools to time your Fortress Biotech Inc. exitJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com
Is Fortress Biotech Inc.(CNB0) stock a top hedge fund pickJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
Should I hold or sell Fortress Biotech Inc. stock in 2025Trade Ideas & Weekly Top Gainers Trade List - newser.com
Can a trend reversal in Fortress Biotech Inc. lead to recoveryMarket Sentiment Report & Weekly Momentum Picks - newser.com
How Fortress Biotech Inc.(CNB0) stock trades after rate cutsWeekly Gains Report & Smart Money Movement Tracker - newser.com
Is Fortress Biotech Inc.(CNB0) stock a top dividend aristocrat candidateJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
Can Fortress Biotech Inc. stock attract ESG capital inflows2025 Macro Impact & Consistent Income Trade Ideas - newser.com
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):